InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ENANTA PHARMACEUTICALS INC

ENTA Clue Score19
United States Fiscal year ends September CIK 0001177648
$12.50 +3.31% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $12.50 −82.35% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue102.8Operating income24.6Net income17.7EPS, diluted0.91Fiscal year 2018Revenue206.6 +101.0%Operating income88.3Net income72.0 +306.3%EPS, diluted3.48Fiscal year 2019Revenue205.2 −0.7%Operating income36.7Net income46.4 −35.5%EPS, diluted2.21Fiscal year 2020Revenue122.5 −40.3%Operating income−41.6Net income−36.2 −178.0%EPS, diluted−1.81Fiscal year 2021Revenue97.1 −20.7%Operating income−109.6Net income−79.0EPS, diluted−3.92Fiscal year 2022Revenue86.2 −11.2%Operating income−123.8Net income−121.8EPS, diluted−5.91Fiscal year 2023Revenue79.2 −8.1%Operating income−137.2Net income−133.8EPS, diluted−6.38Fiscal year 2024Revenue67.6 −14.6%Operating income−121.7Net income−116.0EPS, diluted−5.48Fiscal year 2025Revenue65.3 −3.4%Operating income−85.3Net income−81.9EPS, diluted−3.84
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 102.8 206.6 205.2 122.5 97.1 86.2 79.2 67.6 65.3
Growth +101.0% −0.7% −40.3% −20.7% −11.2% −8.1% −14.6% −3.4%
Operating income 24.6 88.3 36.7 −41.6 −109.6 −123.8 −137.2 −121.7 −85.3
Net income 17.7 72.0 46.4 −36.2 −79.0 −121.8 −133.8 −116.0 −81.9
Growth +306.3% −35.5% −178.0%
EPS, diluted 0.91 3.48 2.21 −1.81 −3.92 −5.91 −6.38 −5.48 −3.84

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2017Operating margin23.9%Net margin17.2%Free cash flow margin48.8%Fiscal year 2018Operating margin42.7%Net margin34.8%Free cash flow margin12.7%Fiscal year 2019Operating margin17.9%Net margin22.6%Free cash flow margin32.2%Fiscal year 2020Operating margin−34.0%Net margin−29.5%Free cash flow margin4.6%Fiscal year 2021Operating margin−112.9%Net margin−81.4%Free cash flow margin−72.9%Fiscal year 2022Operating margin−143.7%Net margin−141.3%Free cash flow margin−100.9%Fiscal year 2023Operating margin−173.2%Net margin−169.0%Free cash flow margin−141.7%Fiscal year 2024Operating margin−179.9%Net margin−171.6%Free cash flow margin−143.0%Fiscal year 2025Operating margin−130.7%Net margin−125.4%Free cash flow margin−49.2%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin 23.9% 42.7% 17.9% −34.0% −112.9% −143.7% −173.2% −179.9% −130.7%
Net margin 17.2% 34.8% 22.6% −29.5% −81.4% −141.3% −169.0% −171.6% −125.4%
Free cash flow margin 48.8% 12.7% 32.2% 4.6% −72.9% −100.9% −141.7% −143.0% −49.2%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow52.7Capital expenditure−2.5Free cash flow50.1Fiscal year 2018Operating cash flow29.2Capital expenditure−3.0Free cash flow26.2 −47.7%Fiscal year 2019Operating cash flow71.4Capital expenditure−5.4Free cash flow66.0 +151.5%Fiscal year 2020Operating cash flow7.1Capital expenditure−1.4Free cash flow5.6 −91.5%Fiscal year 2021Operating cash flow−70.0Capital expenditure−0.8Free cash flow−70.7 −1,353.7%Fiscal year 2022Operating cash flow−84.8Capital expenditure−2.1Free cash flow−86.9Fiscal year 2023Operating cash flow−103.2Capital expenditure−9.1Free cash flow−112.2Fiscal year 2024Operating cash flow−78.8Capital expenditure−17.9Free cash flow−96.7Fiscal year 2025Operating cash flow−19.3Capital expenditure−12.9Free cash flow−32.2
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 52.7 29.2 71.4 7.1 −70.0 −84.8 −103.2 −78.8 −19.3
Capital expenditure −2.5 −3.0 −5.4 −1.4 −0.8 −2.1 −9.1 −17.9 −12.9
Free cash flow 50.1 26.2 66.0 5.6 −70.7 −86.9 −112.2 −96.7 −32.2
Growth −47.7% +151.5% −91.5% −1,353.7%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2017Cash65.7Shareholders’ equity301.7Fiscal year 2018Cash63.9Shareholders’ equity393.7Fiscal year 2019Cash51.2Shareholders’ equity462.5Fiscal year 2020Cash87.1Shareholders’ equity455.6Fiscal year 2021Cash57.2Shareholders’ equity399.4Fiscal year 2022Cash44.0Shareholders’ equity321.3Fiscal year 2023Cash85.4Shareholders’ equity216.7Fiscal year 2024Cash37.2Shareholders’ equity128.8Fiscal year 2025Cash32.3Shareholders’ equity64.7
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 65.7 63.9 51.2 87.1 57.2 44.0 85.4 37.2 32.3
Shareholders’ equity 301.7 393.7 462.5 455.6 399.4 321.3 216.7 128.8 64.7

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending September, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 30 Sep 2017 FY2018 30 Sep 2018 FY2019 30 Sep 2019 FY2020† 30 Sep 2020 FY2021 30 Sep 2021 FY2022 30 Sep 2022 FY2023 30 Sep 2023 FY2024 30 Sep 2024 FY2025 30 Sep 2025
Revenue and profit
102.8 206.6 205.2 122.5 97.1 86.2 79.2 67.6 65.3
Growth +101.0% −0.7% −40.3% −20.7% −11.2% −8.1% −14.6% −3.4%
57.5 94.9 142.2 136.8 174.1 164.5 163.5 131.5 106.7
20.7 23.4 26.2 27.4 32.5 45.5 52.9 57.9 43.9
24.6 88.3 36.7 −41.6 −109.6 −123.8 −137.2 −121.7 −85.3
Growth +258.9% −58.4% −213.3%
26.9 93.1 45.6 −35.0 −107.6 −122.2 −131.0 −117.8 −83.5
9.2 21.2 −0.8 1.1 −28.6 −0.4 2.8 −1.7 −1.7
17.7 72.0 46.4 −36.2 −79.0 −121.8 −133.8 −116.0 −81.9
Growth +306.3% −35.5% −178.0%
Per share
0.93 3.74 2.37 −1.81 −3.92 −5.91 −6.38 −5.48 −3.84
0.91 3.48 2.21 −1.81 −3.92 −5.91 −6.38 −5.48 −3.84
Growth +282.4% −36.5% −181.9%
19.1 19.3 19.6 0.0 0.0 0.0 0.0 0.0 0.0
19.4 20.7 21.0 0.0 0.0 0.0 0.0 0.0 0.0
Growth +6.4% +1.5% −99.9% +1.2% +2.1% +1.8% +0.9% +0.8%

† The diluted share count jumps at 2020, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 11.8% a year over five years.
  • Operating margin is down 96.7 points on five years ago, at -130.7%.
  • A net loss in 6 of 9 years on file.